ES2118846T3 - Formas cristalinas de monohidrato de hidrocloruro de endo-2,3-dihidro-n-(8-metil-8-azabiciclo(3.2.1)oct-3-il)-2-oxo-1h-bencimidazol-1-carboxamida y de monohidrato de hidrocloruro de endo-3-etil-2,3-dihidro-n-(8-metil-8-azabiciclo(3.2.1)oct-3-il)-2-oxo-1h-bencimidazol-1-carboxamid - Google Patents

Formas cristalinas de monohidrato de hidrocloruro de endo-2,3-dihidro-n-(8-metil-8-azabiciclo(3.2.1)oct-3-il)-2-oxo-1h-bencimidazol-1-carboxamida y de monohidrato de hidrocloruro de endo-3-etil-2,3-dihidro-n-(8-metil-8-azabiciclo(3.2.1)oct-3-il)-2-oxo-1h-bencimidazol-1-carboxamid

Info

Publication number
ES2118846T3
ES2118846T3 ES93104564T ES93104564T ES2118846T3 ES 2118846 T3 ES2118846 T3 ES 2118846T3 ES 93104564 T ES93104564 T ES 93104564T ES 93104564 T ES93104564 T ES 93104564T ES 2118846 T3 ES2118846 T3 ES 2118846T3
Authority
ES
Spain
Prior art keywords
endo
dihydro
oct
methyl
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93104564T
Other languages
English (en)
Inventor
Enzo Cereda
Enrica Dubini
Antoine Ezhaya
Grazia Maffione
Marco Turconi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Italia SpA
Original Assignee
Boehringer Ingelheim Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI920720A external-priority patent/IT1254562B/it
Priority claimed from ITMI920723A external-priority patent/IT1254565B/it
Application filed by Boehringer Ingelheim Italia SpA filed Critical Boehringer Ingelheim Italia SpA
Application granted granted Critical
Publication of ES2118846T3 publication Critical patent/ES2118846T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE PRESENTAN MONOHIDRATOS CRISTALINOS DE HIDROCLORURO DE ENDO-2,3-DIHIDRO-N-(8-METIL-8-AZABICICLO[3-2,1]OCT-3-IL)-2-OXO-1H-BENZIMIDAZOLA-1-CARBOXAMIDO Y DE HIDROCLORURO DE ENDO-3-ETIL-2,3-DIHIDRO-N-(8-METIL.-8-AZABICICLO[3.2.1]OCT-3-IL)2-OXO1H-BENZIMIDAZOLA-1-CARBOXAMIDO DE LA FORMULA I (COMPUESTO 2A: R = H) (COMPUESTO 2B: R = C2H5), ASIMISMO SE PRESENTA EL PROCESO PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
ES93104564T 1992-03-26 1993-03-19 Formas cristalinas de monohidrato de hidrocloruro de endo-2,3-dihidro-n-(8-metil-8-azabiciclo(3.2.1)oct-3-il)-2-oxo-1h-bencimidazol-1-carboxamida y de monohidrato de hidrocloruro de endo-3-etil-2,3-dihidro-n-(8-metil-8-azabiciclo(3.2.1)oct-3-il)-2-oxo-1h-bencimidazol-1-carboxamid Expired - Lifetime ES2118846T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI920720A IT1254562B (it) 1992-03-26 1992-03-26 Forma cristallina dell'endo-3-etil-2,3-diidro-n-(8-metil-8-azabiciclo (3.2.1) ott-3-il)- 2-oxo-1h-benzimidazolo-1-carbossamide cloridrato
ITMI920723A IT1254565B (it) 1992-03-26 1992-03-26 Forma cristallina dell'endo-2,3-diidro-n-(8 metil-8-azabiciclo-(3.2.1) ott-3-il)-2-oxo-1h-benzimidazolo-1-carbossamide cloridrato

Publications (1)

Publication Number Publication Date
ES2118846T3 true ES2118846T3 (es) 1998-10-01

Family

ID=26330860

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93104564T Expired - Lifetime ES2118846T3 (es) 1992-03-26 1993-03-19 Formas cristalinas de monohidrato de hidrocloruro de endo-2,3-dihidro-n-(8-metil-8-azabiciclo(3.2.1)oct-3-il)-2-oxo-1h-bencimidazol-1-carboxamida y de monohidrato de hidrocloruro de endo-3-etil-2,3-dihidro-n-(8-metil-8-azabiciclo(3.2.1)oct-3-il)-2-oxo-1h-bencimidazol-1-carboxamid

Country Status (28)

Country Link
US (1) US5468758A (es)
EP (1) EP0567767B1 (es)
JP (1) JP3279707B2 (es)
AT (1) ATE169016T1 (es)
AU (1) AU654082B2 (es)
BR (1) BR1100564A (es)
CA (1) CA2092510C (es)
CZ (1) CZ286590B6 (es)
DE (1) DE69319955T2 (es)
DK (1) DK0567767T3 (es)
ES (1) ES2118846T3 (es)
FI (1) FI113472B (es)
HK (1) HK1010719A1 (es)
HR (1) HRP930479B1 (es)
HU (2) HU211075B (es)
IL (1) IL105143A (es)
MX (1) MX9301668A (es)
NO (1) NO300975B1 (es)
NZ (1) NZ247234A (es)
PH (1) PH30413A (es)
PL (1) PL172890B1 (es)
RU (1) RU2125054C1 (es)
SG (1) SG43225A1 (es)
SI (1) SI9300150B (es)
SK (1) SK280555B6 (es)
TW (1) TW385310B (es)
UA (1) UA37179C2 (es)
UY (2) UY25939A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1282015B1 (en) 1996-01-17 2005-05-11 Ricoh Company, Ltd. Fixing apparatus for an image forming apparatus
JPH1039679A (ja) * 1996-05-24 1998-02-13 Ricoh Co Ltd 定着装置
PE20001420A1 (es) 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
US8697722B2 (en) * 2007-11-02 2014-04-15 Sri International Nicotinic acetylcholine receptor modulators
CN102905527B (zh) * 2010-01-11 2016-08-24 阿斯特来亚治疗有限责任公司 烟碱型乙酰胆碱受体调节剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223511A (en) * 1987-09-23 1993-06-29 Boehringer Ingelheim Italia S.P.A. Benzimidazoline-2-oxo-1-carboxylic acid compounds useful as 5-HT receptor antagonists
GB9121835D0 (en) * 1991-10-15 1991-11-27 Smithkline Beecham Plc Pharmaceuticals
EP0554794B1 (en) * 1992-02-04 1998-07-29 Eisai Co., Ltd. Aminobenzoic acid derivatives

Also Published As

Publication number Publication date
HRP930479B1 (en) 1999-10-31
PH30413A (en) 1997-05-09
HK1010719A1 (en) 1999-06-25
SI9300150A (en) 1993-09-30
AU654082B2 (en) 1994-10-20
CA2092510C (en) 2004-02-03
HU9300868D0 (en) 1993-06-28
RU2125054C1 (ru) 1999-01-20
IL105143A (en) 1996-10-16
UA37179C2 (uk) 2001-05-15
BR1100564A (pt) 2000-06-27
NO931112L (no) 1993-09-27
CA2092510A1 (en) 1993-09-27
CZ286590B6 (cs) 2000-05-17
DE69319955T2 (de) 1999-04-15
FI113472B (fi) 2004-04-30
SG43225A1 (en) 1997-10-17
AU3541393A (en) 1993-09-30
UY25938A1 (es) 2000-09-29
FI931329A0 (fi) 1993-03-25
EP0567767A1 (en) 1993-11-03
PL298263A1 (en) 1994-01-10
EP0567767B1 (en) 1998-07-29
UY25939A1 (es) 2001-08-27
MX9301668A (es) 1993-09-01
CZ44393A3 (en) 1994-01-19
JP3279707B2 (ja) 2002-04-30
HU211075B (en) 1995-10-30
FI931329A (fi) 1993-09-27
DE69319955D1 (de) 1998-09-03
SK280555B6 (sk) 2000-03-13
SI9300150B (sl) 1998-06-30
SK22693A3 (en) 1993-11-10
US5468758A (en) 1995-11-21
NZ247234A (en) 1995-12-21
PL172890B1 (pl) 1997-12-31
NO931112D0 (no) 1993-03-25
ATE169016T1 (de) 1998-08-15
HUT63846A (en) 1993-10-28
HU211131A9 (en) 1995-10-30
HRP930479A2 (en) 1995-02-28
NO300975B1 (no) 1997-08-25
DK0567767T3 (da) 1999-02-01
JPH0673053A (ja) 1994-03-15
TW385310B (en) 2000-03-21

Similar Documents

Publication Publication Date Title
HU9302329D0 (en) 7-(substituted)-9-|(substituted glycyl)-amino¨-6-desmethyl-6-desoxy-tetracyclines, pharmaceutical preparatives containing them and methods for producing them
HU9302330D0 (en) 7-(substituted)-9-|(substituted glycyl)-amino¨-6-desmethyl-6-desoxy-tetracyclines, pharmaceutical preparatives containing them and methods for producing them
NO942953L (no) 11-benzaldoksimestradienderivater, fremgangsmåte for deres fremstilling smat legemddel inneholdende slike
IL106677A0 (en) Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines
IL111275A (en) Derivatives of 6-demethylgalanthamine, their mono-and di-esters and pharmaceutical compositions containing them
IL91001A0 (en) N-alkyl derivatives of antibiotic bu-3608 complex and pharmaceutical compositions containing them
ES2118846T3 (es) Formas cristalinas de monohidrato de hidrocloruro de endo-2,3-dihidro-n-(8-metil-8-azabiciclo(3.2.1)oct-3-il)-2-oxo-1h-bencimidazol-1-carboxamida y de monohidrato de hidrocloruro de endo-3-etil-2,3-dihidro-n-(8-metil-8-azabiciclo(3.2.1)oct-3-il)-2-oxo-1h-bencimidazol-1-carboxamid
IL108085A0 (en) Serotoninergic ergoline derivatives their preparation and pharmacutical compositions containing them
GR3017280T3 (en) Aminoalkylchromones, process for their preparation and compositions containing them.
IT1254562B (it) Forma cristallina dell&#39;endo-3-etil-2,3-diidro-n-(8-metil-8-azabiciclo (3.2.1) ott-3-il)- 2-oxo-1h-benzimidazolo-1-carbossamide cloridrato
IT1254565B (it) Forma cristallina dell&#39;endo-2,3-diidro-n-(8 metil-8-azabiciclo-(3.2.1) ott-3-il)-2-oxo-1h-benzimidazolo-1-carbossamide cloridrato
EP0080592B1 (en) A novel vasodilator compound, process for the preparation thereof and pharmaceutical compositions thereform
IL109227A0 (en) Leustroducsin h, pharmaceutical composition containing the same, and processes for the preparation thereof
GR3020922T3 (en) Amide derivatives of 1-amino-octahydropyrido[2,1-c][1,4]oxazine, processes for their preparation and pharmaceutical compositions containing them
ES8703421A1 (es) Procedimiento para preparar derivados de pirrolidindiona.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 567767

Country of ref document: ES